Form 4: Firefly Neuroscience Chairman Granted Deferred Stock Units

Arun Swarup Menawat, Chairman of Firefly Neuroscience, received 16,667 Deferred Stock Units (DSUs) under the company's 2024 Long-Term Incentive Plan.

Summary

• On March 10, 2025, Arun Swarup Menawat, Chairman of Firefly Neuroscience, was granted 16,667 Deferred Stock Units (DSUs) under the Issuer's 2024 Long-Term Incentive Plan.
• 8,333 DSUs vested immediately on the grant date.
• An additional 4,167 DSUs will vest on June 10, 2025, and another 4,167 DSUs will vest on September 10, 2025.
• Each DSU represents a contingent right to receive one share of Firefly Neuroscience common stock.

Sentiment

Score: 7

Explanation: The grant of DSUs is a positive sign of alignment between management and shareholders, and the vesting schedule incentivizes continued service. However, it's a routine event and doesn't necessarily indicate a major shift in the company's prospects.

Positives

• The grant of DSUs to the Chairman aligns his interests with those of the shareholders.
• The vesting schedule incentivizes continued service and contribution to the company's success.

Future Outlook

The vesting schedule of the DSUs suggests an expectation of continued service and contribution from the Chairman through September 2025.

Industry Context

Grants of deferred stock units are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders and incentivizing long-term value creation.

Stakeholder Impact

• Shareholders may view the DSU grant as a positive sign of alignment between management and shareholder interests.
• The vesting schedule incentivizes the Chairman to continue contributing to the company's success, which could benefit all stakeholders.

Key Dates